NAOV - NanoVibronix says study shows benefit of UroShield in spinal cord injury patients

2023-03-14 09:44:48 ET

• NanoVibronix ( NASDAQ: NAOV ) said an independent study showed that the UroShield device helped decrease the number of blockages and infections and increased catheter satisfaction in patients with spinal cord injury.
• The company presented the results a recent medical conference by clinicians from the Royal National Orthopaedic Hospital (RNOH).
• NanoVibronix said that evaluators also noted that the device has the potential to improve quality of life and reduce healthcare linked costs for patients with spinal cord injuries who have recurrent blockages or infections and those with complicated catheter issues.
• "Feedback collected from patients that participated in the study affirms that UroShield is straightforward to use, of benefit to patients’ physical and mental health and in at least one case, was instrumental in preventing a hospital stay," said NanoVibronix CEO Brian Murphy.
• UroShield is a device used to cut the risk of catheter linked urinary tract infection and reduces catheter pain and discomfort.

For further details see: